Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy

Volume: 13, Issue: 14, Pages: 3562 - 3562
Published: Jul 16, 2021
Abstract
Brain-specific angiogenesis inhibitor 1 (BAI1/ADGRB1) is an adhesion G protein-coupled receptor that has been found to play key roles in phagocytosis, inflammation, synaptogenesis, the inhibition of angiogenesis, and myoblast fusion. As the name suggests, it is primarily expressed in the brain, with a high expression in the normal adult and developing brain. Additionally, its expression is reduced in brain cancers, such as glioblastoma (GBM) and...
Paper Details
Title
Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy
Published Date
Jul 16, 2021
Journal
Volume
13
Issue
14
Pages
3562 - 3562
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.